265 results
·
17ms
·
Sources: EU EUDAMED, US FDA
Filters
Classification: FDA Class 3
×
Stent, Central Venous
FDA Pre-Market Approval
FDA Class 3
·WALLSTENT (VENOUS) ENDOPROSTHESIS
Stent, Central Venous
FDA Pre-Market Approval
FDA Class 3
·VENOUS WALLSTENT Self-Expanding Stent
Immunocytochemistry Assay, P16/Ki-67
FDA Pre-Market Approval
FDA Class 3
·CINtec PLUS Cytology
Stent, Central Venous
FDA Pre-Market Approval
FDA Class 3
·WALLSTENT (TIPS,ILIAC,VENOUS) ENDOPROSTHESIS WITH UNISTEP PLUS DELIVERY SYSTEMS
Immunocytochemistry Assay, P16/Ki-67
FDA Pre-Market Approval
FDA Class 3
·CINtec PLUS Cytology
Stent, Central Venous
FDA Pre-Market Approval
FDA Class 3
·WALLSTENT ENDOPROSTHESIS WITH UNISTEP PLUS DELIVERY SYSTEM
Stent, Central Venous
FDA Pre-Market Approval
FDA Class 3
·WALLSTENT (TIPS AND VENOUS) ENDOPROSTHESIS WITH UNISTEP PLUS DELIVERY SYSTEM
Stent, Central Venous
FDA Pre-Market Approval
FDA Class 3
·Wallstent (Venous) Endoprosthesis with Unistep Plus Delivery System
Stent, Central Venous
FDA Pre-Market Approval
FDA Class 3
·WALLSTENT ENDOPROSTHESIS VENOUS
Stent, Central Venous
FDA Pre-Market Approval
FDA Class 3
·WALLSTENT Venous Endoprosthesis with Unistep Plus Delivery System
Hepatitis Viral B Dna Detection
FDA Pre-Market Approval
FDA Class 3
·ABBOTT REALTIME HBV ASSAY
Next Generation Sequencing Oncology Panel, Somatic Or Germline Variant Detection System
FDA Pre-Market Approval
FDA Class 3
·FoundationOne CDx (F1CDx)
Somatic Gene Mutation Detection System
FDA Pre-Market Approval
FDA Class 3
·therascreen PIK3CA RGQ PCR Kit
Somatic Gene Mutation Detection System
FDA Pre-Market Approval
FDA Class 3
·therascreen FGFR RGQ PCR Kit
Somatic Gene Mutation Detection System
FDA Pre-Market Approval
FDA Class 3
·therascreen KRAS RGQ PCR Kit
Somatic Gene Mutation Detection System
FDA Pre-Market Approval
FDA Class 3
·therascreen EGFR RGQ PCR Kit
Next Generation Sequencing Oncology Panel, Somatic Or Germline Variant Detection System
FDA Pre-Market Approval
FDA Class 3
·Praxis Extended RAS Panel
Fluorescence In Situ Hybridization, Topoisomerase Ii Alpha, Gene Amplification And Deletion
FDA Pre-Market Approval
FDA Class 3
·TOP2A FISH PHARMDX KIT
Immunohistochemistry Assay, Antibody, Programmed Death-Ligand 1
FDA Pre-Market Approval
FDA Class 3
·PD-L1 IHC 22C3 pharmDx
Next Generation Sequencing Oncology Panel, Somatic Or Germline Variant Detection System
FDA Pre-Market Approval
FDA Class 3
·MiSeqDx Extended RAS Panel